KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Charles River Laboratories International (CRL) FCF Margin (2016 - 2025)

Charles River Laboratories International has reported FCF Margin over the past 17 years, most recently at 5.89% for Q4 2025.

  • For Q4 2025, FCF Margin fell 246.0% year-over-year to 5.89%; the TTM value through Dec 2025 reached 12.91%, up 53.0%, while the annual FY2025 figure was 12.91%, 53.0% up from the prior year.
  • FCF Margin for Q4 2025 was 5.89% at Charles River Laboratories International, down from 17.74% in the prior quarter.
  • Over five years, FCF Margin peaked at 21.1% in Q3 2024 and troughed at 0.24% in Q2 2023.
  • A 5-year average of 11.27% and a median of 13.28% in 2021 define the central range for FCF Margin.
  • Biggest five-year swings in FCF Margin: skyrocketed 1118bps in 2021 and later tumbled -1482bps in 2022.
  • Year by year, FCF Margin stood at 14.42% in 2021, then decreased by -8bps to 13.25% in 2022, then increased by 6bps to 14.07% in 2023, then tumbled by -41bps to 8.35% in 2024, then dropped by -29bps to 5.89% in 2025.
  • Business Quant data shows FCF Margin for CRL at 5.89% in Q4 2025, 17.74% in Q3 2025, and 16.4% in Q2 2025.